Literature DB >> 1002820

Restoration of plasma testosterone levels in uremic men with clomiphene citrate.

V S Lim, V S Fang.   

Abstract

Five men with chronic renal failure and symptoms suggestive to androgen deficiency were treated with clomiphene citrate (Clomid) at a dose of 100 mg/day for a period of 5 to 12 months. The treatment resulted uniformly in increased libido, sexual potency, and a general sense of well-being. Circulating testosterone rose from mean basal value of 223 +/- 164 to 879 +/- 171 ng/dl (SD), representing a mean increment of 290%. Mean serum lutenizing hormone (LH) and follicle-stimulating hormone (FSH) values before treatment were 76 +/- 40 and 143 +/- 85 ng/ml (SD). During treatment, both LH and FSH increased dramatically to 518 +/- 302 and 787 +/- 291 ng/ml (SD), respectively. Both serum gonadotropin values are expressed as ng/ml of LER 907. The effect of clomiphene on spermatogenesis in these subjects was inconclusive as either improvement or deterioration occured. In these five patients, serum prolactin was not related in any way to testicular function as its values were consistently in the normal range throughout the entire study period. Serum total estrogen, however, was elevated in all; the significance of this high circulating estrogen in relation to gonadal dysfunction in uremia is not clear at the present time. However, we found that normalization of circulating androgen was beneficial to our patients and that long-term clomiphene treatment achieved this goal by increasing pituitary gonadotropin secretion and secondarily stimulating testicular hormonogenesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1002820     DOI: 10.1210/jcem-43-6-1370

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Gonadal dysfunction in chronic kidney disease.

Authors:  Biff F Palmer; Deborah J Clegg
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 2.  Chronic kidney disease and erectile dysfunction.

Authors:  Etsu Suzuki; Hiroaki Nishimatsu; Shigeyoshi Oba; Masao Takahashi; Yukio Homma
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Systemic illness.

Authors:  Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Ettore C degli Uberti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 4.  Enclomiphene citrate for the treatment of secondary male hypogonadism.

Authors:  Katherine M Rodriguez; Alexander W Pastuszak; Larry I Lipshultz
Journal:  Expert Opin Pharmacother       Date:  2016-07-04       Impact factor: 3.889

5.  A prospective analysis of testicular androgenic function in recipients of a renal allograft.

Authors:  Rajiv Yadav; S N Mehta; A Kumar; S Guleria; V Seenu; S C Tiwari
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

6.  Loss of pulsatile luteinising hormone secretion in men with chronic renal failure.

Authors:  R S Rodger; L Morrison; J H Dewar; R Wilkinson; M K Ward; D N Kerr
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-07

7.  Sexual and gonadal dysfunction in chronic kidney disease: Pathophysiology.

Authors:  Manish Rathi; Raja Ramachandran
Journal:  Indian J Endocrinol Metab       Date:  2012-03

Review 8.  Alternatives to testosterone replacement: testosterone restoration.

Authors:  Andrew McCullough
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

9.  Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone.

Authors:  Dag Eckersten; Aleksander Giwercman; Anders Christensson
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

10.  The Impact of Hemodialysis on Sexual Function in Male Patients using the International Index of Erectile Function Questionnaire (IIEF).

Authors:  Hossein Savadi; Morteza Khaki; Maryam Javnbakht; Hasan Pourrafiee
Journal:  Electron Physician       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.